Scarica l'app Stockscreener
7.1035
1.80%
-0.1165
Precedente Chiudi:
$7.22
Aprire:
$7.29
Volume 24 ore:
25,781
Relative Volume:
0.09
Capitalizzazione di mercato:
$195.22M
Reddito:
$61.86M
Utile/perdita netta:
$-11.43M
Rapporto P/E:
-14.74
EPS:
-0.4818
Flusso di cassa netto:
$-12.52M
1 W Prestazione:
+0.14%
1M Prestazione:
+18.76%
6M Prestazione:
-5.47%
1 anno Prestazione:
-0.28%
Intervallo 1D:
$7.00
$7.33
Intervallo di 1 settimana:
$6.89
$7.33
Portata 52W:
$4.31
$9.555
Journey Medical Corp Stock (DERM) Company Profile
Nome
Journey Medical Corp
Settore
Telefono
480-434-6670
Indirizzo
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.09 | 195.22M | 61.86M | -11.43M | -12.52M | -0.4818 |
TAK
Takeda Pharmaceutical Co Adr
|
17.06 | 52.99B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.92 | 43.25B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.79 | 40.34B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.00 | 31.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
556.63 | 23.60B | 3.17B | 1.29B | 1.01B | 27.09 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-30 | Ripresa | B. Riley Securities | Buy |
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-28 | Ripresa | ROTH MKM | Buy |
| 2021-12-07 | Iniziato | B. Riley Securities | Buy |
Journey Medical Corp Borsa (DERM) Ultime notizie
Form 4 Journey Medical Corp For: 26 June By Investing.com - Investing.com Nigeria
Director at Journey Medical (DERM) receives 10,000 restricted stock units - Stock Titan
Journey Medical (DERM) director awarded 10,000 restricted stock units in equity grant - Stock Titan
Journey Medical (DERM) director receives 10,000 RSUs vesting in 2027 - Stock Titan
Journey Medical (DERM) director granted 10,000 RSUs, holds over 397K shares - Stock Titan
Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo! Finance Canada
Journey Medical Corporation (DERM) Files Form 8-K with SEC – Key Company Details and Filing Information (June 24, 2026) – Minichart - Minichart
Journey Medical Shareholders Back Board and Auditor Slate - TipRanks
Journey Medical (DERM) 2026 meeting backs all directors and re-approves KPMG - Stock Titan
Journey Medical Corp. Actuals & Estimates (NASDAQ:DERM) - TradingView
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Yahoo Finance
Journey Medical Corp (DERM) Institutional Confidence - TradingKey
Best Travel Insurance Companies For 2026: Expert-Rated - Forbes
Journey Medical Corp (DERM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fortress Biotech (NASDAQ: FBIO) reports 2026 director and auditor vote tallies - Stock Titan
Best travel insurance if you have a medical condition 2026 - which.co.uk
AI lab Midjourney investing over $74M to launch whole-body ultrasound screening business - Radiology Business
Journey Medical Corp (DERM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Journey Medical Corp (DERM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Journey Medical Corp (DERM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Journey Medical Corp (DERM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Journey Medical Corp (DERM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Journey Medical Corp (DERM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Journey Medical Corp (DERM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DERM Stock Price, Quote & Chart - ChartMill
Clínica de Especialidades Oftalmológicas (CEO) Becomes First Organization in the World Accredited Under GHA Healthcare Organization Standards 1.0 and GHA Integrated Accreditation for Medical Travel - Morningstar
Este Medical Group Announces Enhanced Consultation and Aftercare Pathway for International Hair Transplant Patients - Digital Journal
How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation Target - Yahoo Finance
Journey Medical Shares Drop—DERM’s 2026 Outlook Hinges on Emrosi Trial - Bez Kabli
10 Best Travel Insurance Companies For 2026 - Forbes
Journey Medical Corp stock (US48113J1007): calm start to the week after recent gains - AD HOC NEWS
Medical AI Market Size & Share | Industry Report, 2026-2033 - Grand View Research
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: Journey Medical Q1 2026 shows 21% revenue rise - Investing.com
Journey Medical Analyst Ratings and Price Targets | NASDAQ:DERM - Benzinga
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Iridex (IRIX) - The Globe and Mail
Journey Medical CEO to join A.G.P. Virtual Healthcare Conference fireside chat on May 20, 2026 - Pluang
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference - The Manila Times
Journey Medical CEO to join online talk at A.G.P. health event - Stock Titan
Journey Medical Corp stock (US48113J1007): dermatology player in focus after recent financing update - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceuticals (SPRY) - The Globe and Mail
Journey Medical Corporation (NASDAQ:DERM) Q1 2026 Earnings Call Transcript - Insider Monkey
Lake Street Sticks to Its Buy Rating for Journey Medical Corp (DERM) - The Globe and Mail
Journey Medical Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Analyst Reiterates Buy on Journey Medical, Maintains $13 Price Target After Strong 1Q26 and Emrosi Momentum - TipRanks
Journey Medical Corp stock (US48113J1007): Q1 revenue jumps 21% to $16M - AD HOC NEWS
Journey Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings - Yahoo Finance
Earnings call transcript: Journey Medical Q1 2026 reports strong EPS beat - Investing.com
Journey Medical Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Journey Medical Q1 2026 shows strong revenue growth - Investing.com
Journey Medical Corp Azioni (DERM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.67%
1.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):